The Infusion Edge

The Infusion Edge is your quarterly inside track to the future of our industry, delivering actionable market intelligence and reimbursement policy updates. Each issue highlights member and partner achievements, exclusive partner-driven insights, and new opportunities to grow and lead the way forward—together.

A Message from Leadership

Momentum for 2026

As we step into 2026, Infinity Infusion Solutions proudly celebrates over a decade of impact built on resilience, trust, and partnership. What began with conviction and courage has grown into a nationally trusted network of more than 2,600 independent members committed to advancing infusion care. Through industry headwinds, competitive pressure, rising drug costs, and reimbursement challenges, we never wavered. Our focus has remained constant: protecting patient access, affordability, and continuity of care. We didn’t just build a company—we built a community rooted in purpose and perseverance.

Looking ahead, 2026 marks a pivotal chapter of innovation and strategic growth. We are strengthening our team, deepening partnerships with organizations like NICA and IPA, expanding our distributor network with the addition of Cencora, and investing in enhanced technology to better support our members. As industry dynamics continue to shift, IIS remains proactive, advocacy-driven, and positioned to lead. Aligned, we move Forward Together—10 Years Strong—committed to building a more connected infusion community and shaping the future of care.

Tamra Townsend, CEO | Katie Ivy, COO

Built on trust. Focused on patients. Leading the way forward.

A look at what’s ahead

Industry news: IIS has officially partnered with Cencora, expanding our distributor network to offer streamlined ordering while maintaining full authority over pricing and rebates.

New hires: We are excited to welcome Aubree Beitzinger (Sales & Manufacturing Associate) and Pedram Pahlavan (AVP of Industry Relations) to the IIS family!

Coming soon: Be on the lookout for the launch of CompassIQ™, our proprietary member access portal, launching in the 1st half of 2026. It will empower members to track:

• Purchasing history and member benefits
• Contract status and current pricing
• Incentive programs and rebates

Upcoming conferences: Look for IIS at these events.

• Drug Channels Leadership Forum: 3/16 – 3/18
• TAAIS (Texas Allergy and Immunology): 4/9 – 4/12
• NHIA26: 4/18 – 4/22
• Asembia: 4/26 - 4/30

Save the Date

Follow us on LinkedIn for the latest updates

Have a question or want to be featured in an upcoming newsletter? Get in touch with us here.

Compliance Corner with IPA

Reimbursement cuts in 2026

IPA shares important guidance on emerging reimbursement challenges, including:

• Medicare Drug Price Negotiation & Maximum Fair Prices (MFPs)
• MFP + 6% vs. ASP + 6% reimbursement risks
• CMS CY 2026 Physician Fee Schedule implications
• Legislative path forward: HR 4299

Partner Perspective with NICA

Protecting access to infusion care

The National Infusion Center Association (NICA) continues to advocate at both the state and federal levels to protect non-hospital, community-based infusion center viability and ensure patient access to life-saving infusion therapies. Key areas of focus include:

• Opposing government price-setting policies that threaten provider sustainability: NICA is actively pushing back against Prescription Drug Affordability Boards (PDABs), Upper Payment Limits (UPLs), and other price-setting proposals that risk reimbursing providers below acquisition cost. These policies jeopardize the buy-and-bill model and...

Sign up here for NICA’s Advocacy Newsletter, the Bi-Weekly PUSH.

Member Provider Spotlight

TwelveStone Health Partners

For more than 10 years, IIS has partnered with TwelveStone Health Partners to deliver proactive advocacy, best-in-class contracting, and consistent results in a competitive infusion marketplace.

Rather than a transactional approach, IIS provides:

• Proactive pursuit of optimized drug agreements
• Deep understanding of provider economics
• Transparent communication and follow-through

The result? Sustained performance, long-term trust, and a partnership that competitors have been unable to replicate.

“We truly value our relationship with IIS. Aside from the great customer service they provide, we are always impressed with their proactive and timely approach to pursuing the best possible agreements and sharing information with us. We have been working with IIS for over a decade, and during that time there has been a steady stream of competitors that have attempted to convert us unsuccessfully because there just hasn’t been anyone in the marketplace that can match the IIS service and results.”

Product & Partner Spotlight

Plasma derived manufacturer

IIS has partnered with a plasma derived manufacturer to accelerate the adoption of buy-and-bill infusion therapies, particularly in neurology and immunology, through ambulatory infusion centers and provider-owned clinics.

IIS goes beyond traditional contracting by providing:

• Direct provider access across a national network of 2,600+ infusion centers
• Tailored operational and reimbursement support for buy-and-bill workflows
• Account activation and reactivation, plus actionable performance insights

The result? A 44% increase in purchasing accounts, ~90% of new accounts introduced through IIS, consistent quarter-over-quarter growth, and reactivation of previously dormant sites—making this manufacturer–IIS partnership the company’s most successful engagement in the alternate site infusion space.

Read the full spotlight

Gratitude & Giving Back

Our Gratitude & Giving Back campaign has officially concluded—and thanks to strong partner participation, we exceeded our feedback survey goal. We’re proud to share that because of your participation, IIS made donations on your behalf to Infusion Providers Alliance (IPA) and National Infusion Center Association (NICA) this past holiday.

⭐We are honored that an overwhelming 93% of members rated IIS customer service a 9/10 or 10/10. Your trust, collaboration, and partnership throughout our first decade is our greatest milestone of all. Thank you for allowing us to grow alongside you. We look forward to continuing to serve, support and advocate for your success in the years ahead, Forward Together.

“IPA is grateful for our partnership with IIS and the opportunity to be included in the Gratitude & Giving Back Initiative. With your support and engagement, we will continue to advance policies that safeguard and strengthen provider-directed, patient focused access to community-based infusion services in the lowest cost, highest quality, clinically appropriate setting of care.”